FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Austin Metcalf’s father rips former Frisco schools chief as ‘spineless’ over Karmelo Anthony graduation

Ivy League student investigated after alleged antisemitic internship rejection: ‘Not working for a Jew’

Left-wing distraction of Trump’s UFC event falls flat as bitter celebrities mocked online

Christian Players for SF Giants Take Bold, Visible Stand Against ‘Pride Month’ and the LGBT Crowd’s Theft of the Rainbow

WATCH: Shane Gillis rejects UFC fighter’s crude Michelle Obama jab after White House win

Watch: UFC Winner Says ‘Michelle Obama Is a Man!’ at White House Following Victory

Jim Acosta ruthlessly mocked for comparing removal of Trump’s name from Kennedy Center to fall of Berlin Wall

Haitian fraudster’s eye-popping taxpayer-backed drug scam puts Congress on the hunt

Horror Discovery: Remains of More Than 30 Unborn Babies Found in Pathologist’s Garden

Stephen A. Smith says ‘Karmelo Anthony murdered Austin Metcalf’

Iran Says Fighting Will End ‘Immediately and Permanently’ After Trump Announces Peace Deal

Zelensky laments Russian attack that damaged 1,000-year-old church

Trump Announces Iran Deal Is Complete, Says Military Operations Will End Immediately

Missouri skydiving plane crash that killed all 12 aboard is a ‘devastating loss,’ company says

Trump bet tariffs would bring back American factory jobs. New report says it didn’t work

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”